To gain insight into the pathogenesis of sialidosis type 1, we performed mo
lecular investigations of two unrelated Japanese patients, Both of them are
compound heterozygotes for base substitutions of (649)G-to-A and (727)G-to
-A, which result in amino acid alterations V217M and G243R, respectively. U
sing homology modeling, the structure of human lysosomal neuraminidase was
constructed and the structural changes caused by these missense mutations w
ere deduced. The predicted change due to V217M was smaller than that caused
by G243R, the latter resulting in a drastic, widespread alteration. The ov
erexpressed gene products containing these mutations had the same molecular
weight as that of the wild type, although the amounts of the products were
moderately decreased. A biochemical study demonstrated that the expressed
neuraminidase containing a V217M mutation was partly transported to lysosom
es and showed residual enzyme activity, although a G243R mutant was retaine
d in the endoplasmic reticulum/Golgi area and had completely lost the enzym
e activity. Considering the data, we surmise that the V217M substitution ma
y be closely associated with the phenotype of sialidosis type 1 with a late
onset and moderate clinical course.